CAS: 41134-88-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | NSC156529 REF: 3D-RBA13488CAS: 41134-88-7 | Min. 95% | To inquire | Fri 20 Dec 24 |
 | NSC156529 REF: TM-T28203CAS: 41134-88-7 | 98% | 2,288.00 €~3,987.00 € | Fri 07 Feb 25 |
NSC156529
CAS:41134-88-7
NSC156529 is a drug candidate that inhibits the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH is an …
Formula:
C28H21ClS2
Purity:
Min. 95%
Molecular weight:
457.1 g/mol
Ref: 3D-RBA13488
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
NSC156529
CAS:41134-88-7
NSC156529 suppresses AKT1, reduces cancer cell growth in vitro, and inhibits prostate tumors in vivo.
Formula:
C28H21ClS2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
457.05
Ref: TM-T28203
| 25mg | 2,288.00 € | ||
| 50mg | 2,949.00 € | ||
| 100mg | 3,987.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
